asco lung cancer highlights, part 3: immunotherapy for stage iii nsclc
Published 11 years ago • 299 plays • Length 8:40Download video MP4
Download video MP3
Similar videos
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
8:45
asco lung cancer highlights, part 2: optimizing radiation for stage iii nsclc
-
6:20
asco lung cancer highlights, part 4: exploring the role of trimodality therapy for stage iii nsclc
-
2:13
lung cancer video library - immunotherapy in stage lll nsclc - the pacific trial and imfinzi
-
2:50
lung cancer video library - das - the role of immunotherapy for unresectable stage 3 nsclc today
-
5:17
immunotherapy in stage iii nsclc - case based panel discussion
-
2:11
asco lung cancer highlights, pt 13: immune checkpoint inhibitor mpdl3280a in advanced nsclc
-
2:53
lung cancer video library - das - what is the role of immunotherapy for unresectable stage lll nsclc
-
2:42
what is stage iii unresectable nsclc?
-
3:47
gracecast - lcvl what is the role of immunotherapy for unresectable stage 3 nsclc today
-
4:20
clinical trial spotlight: determining efficacy of immunotherapy in stage iii lung cancer
-
6:18
the changing standard of care for stage 3 non-small cell lung cancer (nsclc)
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
8:13
asco 2021 lung recap: fda analysis of immunotherapy with or without chemo in adv nsclc and low pdl-1
-
2:28
targeted therapies for stage iii non-small cell lung cancer
-
7:55
gracecast - lcvl - consolidation immunotherapy after chemo-radiation for stage 3 unresectable nsclc
-
2:59
the role of immunotherapy for unresectable stage 3 nsclc mandarin lung cancer video library
-
4:42
asco lung cancer roundtable - new combinations chemo immunotherapy for extensive stage sclc
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023